Viewing Study NCT06536959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-05-10 @ 6:00 AM
Study NCT ID: NCT06536959
Status: RECRUITING
Last Update Posted: 2024-08-05
First Post: 2024-07-31
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: VA Combined With PD-1 Inhibitor for the Treatment of Relapsed and Refractory AML and High-risk MDS
Sponsor: Beijing 302 Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed Acute Myeloid Leukemia View
None Refractory Acute Myeloid Leukemia View
None Myelodysplastic Syndromes View
None Minimal Residual Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Venetoclax View
None Hypomethylation agen View
None PD-1 inhibitor View